NDC properties for "testosterone cypionate 200 MG/ML Injectable Solution" (RxCUI 835840)
About this data
The tables show NDC propoerties for testosterone cypionate 200 MG/ML Injectable Solution with the RxCUI 835840
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for testosterone cypionate 200 MG/ML Injectable Solution (RxCUI 835840)
ANDA | ANDA040530 |
---|---|
ANDA | ANDA085635 |
ANDA | ANDA086030 |
ANDA | ANDA091244 |
ANDA | ANDA201720 |
ANDA | ANDA206368 |
ANDA | ANDA207742 |
ANDA | ANDA210362 |
ANDA | ANDA211817 |
ANDA | ANDA215351 |
MMSL_CODE | CD2937 |
MMSL_CODE | MTH_RXN_BD2937 |
RxCUI | 835840 |
SPL_SET_ID | 108facca-c6d2-48fa-ba48-667c9498c61b |
SPL_SET_ID | 2321a581-2e33-4233-a1d4-0711b90e3c57 |
SPL_SET_ID | 3602f307-19c3-4f09-a3e3-98c10a19ec28 |
SPL_SET_ID | 3653a602-4551-4e6c-84a7-31861f5dc482 |
SPL_SET_ID | 3b0c61de-8cfa-4f76-b07c-0d3b7704b642 |
SPL_SET_ID | 4195516a-c8e6-457c-b805-43c9a3ca8b77 |
SPL_SET_ID | 47df0787-af81-43ca-bd67-1b5d127ff3c3 |
SPL_SET_ID | 4bc98c02-6f63-440e-b3ce-89682ade81f6 |
SPL_SET_ID | 54aee197-7c9c-479f-8a4d-a8d4d31f40c1 |
SPL_SET_ID | 58ff6e0d-cc0a-4455-8254-d883d26a3b6d |
SPL_SET_ID | 5ca67491-4b30-4a47-af0a-be250215d1f0 |
SPL_SET_ID | 66d4ae28-97c2-42cc-ab5a-a765a623c944 |
SPL_SET_ID | 6909596e-4bf7-4e11-8029-b89740a30aec |
SPL_SET_ID | 6bb7d3cc-2b5a-4a48-858e-5421c68b6989 |
SPL_SET_ID | 78d55bad-4a5b-4e21-aeb8-a4c6346208be |
SPL_SET_ID | 8699c6cb-fede-43ea-ad5e-817700fa7a82 |
SPL_SET_ID | 874dec5e-8910-3b3f-e053-2a95a90a8334 |
SPL_SET_ID | 9d0a1923-be39-41d9-8183-706b227f615c |
SPL_SET_ID | ad391b4b-232e-48cf-a226-d8fd750a7c36 |
SPL_SET_ID | ad65b1ec-433e-4524-924e-ebad09762126 |
SPL_SET_ID | b8ac5e07-b7e3-4a60-b0d1-8b1f3ad0c478 |
SPL_SET_ID | c5efc1ed-dd50-48fe-81b6-4d691a178630 |
SPL_SET_ID | cab949ca-fde9-c5a9-5561-21e98d86d078 |
SPL_SET_ID | d7b57b68-dca6-4df2-b3f2-7017d7b69f17 |
SPL_SET_ID | e3e2da65-4b2a-4210-a6ff-cc08c8567381 |
SPL_SET_ID | ed65346b-31bc-f872-516d-78d5ab70229e |
SPL_SET_ID | edcd5209-70db-4727-991e-3fdd185d9211 |
SPL_SET_ID | f60c5520-b336-44a2-95d5-f274939fa595 |
SPL_SET_ID | f901e2b2-f143-4237-8e95-0d134585490b |
SPL_SET_ID | ffb1ae64-9026-44c9-83a0-32058957ecc9 |
VUID | 4001129 |
Prescribable Synonym | testosterone cypionate 200 MG/ML Injectable Solution |
RXNAV_STR | testosterone cypionate 200 MG/ML Injectable Solution |
RxNorm Name | testosterone cypionate 200 MG/ML Injectable Solution |
Related queries | Interactions (for RxCUI 835840) |
NDC Properties
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |
NDC Item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
Packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9005 |
NDC Item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
Packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0143-9726 |
NDC Item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
Packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-6562 |
NDC Item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0820 |
NDC Item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
Packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 584573 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0574-0827 |
NDC Item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
Packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0591-4128 |
NDC Item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
Packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 719526 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 47781-910 |
NDC Item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4147 |
NDC Item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4920 |
NDC Item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
Packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 50090-4921 |
NDC Item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 395393 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 52536-625 |
NDC Item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-278 |
NDC Item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 62756-016 |
NDC Item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
Packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63187-647 |
NDC Item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8705 |
NDC Item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
Packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 63629-8706 |
NDC Item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
Packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-537 |
NDC Item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
Packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 69097-802 |
NDC Item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
Packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70700-290 |
NDC Item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
Packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
Related queries | Properties for NDC 9 72833-678 |
NDC Item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
Packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-065 |
NDC Item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-645 |
NDC Item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-741 |
NDC Item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
Packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-746 |
NDC Item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76420-752 |
NDC Item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
Packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 76519-1210 |